EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient-specific modelling of pulmonary arterial hypertension: wall shear stress correlates with disease severity

C H Armour, D Gopalan, B Statton, D P O'Regan, L Howard, M R Wilkins, X Y Xu, A Lawrie

Frontiers in Bioengineering and Biotechnology · 18.06.2025 · 13

DOI: 10.3389/fbioe.2025.1585345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 18.06.2025. Verfasst von C H Armour und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Heart and Lung Institute, Imperial College London, London, United Kingdom. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pulmonary arterial hypertension (PAH) requires an invasive right heart catheter (RHC) procedure for diagnosis. Patients can present with initial symptoms and interact with healthcare institutes for up to 3 years before referral for diagnosis. Thus, there is a great need to develop non-invasive tools, to better screen patients and improve early diagnosis rates. Methods seven patients diagnosed and treated for PAH were included in this study. Patient-specific computational fluid dynamics (CFD) models were built for all patients, with all model parameters tuned using non-invasive imaging data, including CT, cardiac MR, echocardiogram, and 4D-flow MRI scans–crucially, a 3D inlet velocity profile was derived from 4D-flow MRI.

Results

CFD models were quantitatively and qualitatively well matched with in-vivo 4D-flow hemodynamics. A linear correlation of R 2 = 0.84 was found between CFD derived time-averaged wall shear stress (TAWSS) and RHC measured mean pulmonary pressure (key diagnostic value): low TAWSS correlated with high pressure.

Conclusion

This study highlights TAWSS as a potential computational biomarker for PAH. The clinical use of TAWSS to diagnose and stratify PAH patients has the potential to greatly improve patient outcomes. Further work is ongoing to validate these findings in larger cohorts.

Schlagwörter

Stichwörter der Autor:innen

4D-flow MRIcomputational biomarkercomputational fluid dynamicsnon-invasive assessmentpulmonary arterial hypertensionwall shear stress

Autor:innen und Institutionen

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Department of Chemical Engineering, Imperial College London, London, United Kingdom.
  • National Pulmonary Hypertension Service, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Medical Research Council, Laboratory of Medical Sciences, Imperial College London, London, United Kingdom.

Zitieren

APA

Armour, C. H., Gopalan, D., Statton, B., O'Regan, D. P., Howard, L., Wilkins, M. R., Xu, X. Y., & Lawrie, A. (2025). Patient-specific modelling of pulmonary arterial hypertension: wall shear stress correlates with disease severity. Frontiers in Bioengineering and Biotechnology, 13. https://doi.org/10.3389/fbioe.2025.1585345

Vancouver

Armour CH, Gopalan D, Statton B, O'Regan DP, Howard L, Wilkins MR, et al. Patient-specific modelling of pulmonary arterial hypertension: wall shear stress correlates with disease severity. Frontiers in Bioengineering and Biotechnology. 2025;13. doi:10.3389/fbioe.2025.1585345

BibTeX
@article{Armour2025,
  author = {Armour, C H and Gopalan, D and Statton, B and O'Regan, D P and Howard, L and Wilkins, M R and Xu, X Y and Lawrie, A},
  title = {Patient-specific modelling of pulmonary arterial hypertension: wall shear stress correlates with disease severity},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2025},
  volume = {13},
  doi = {10.3389/fbioe.2025.1585345}
}
Kostenlos starten →